broad-spectrum antibiotic

(redirected from broad-spectrum)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

broad-spectrum antibiotic

[¦brȯd ¦spek·trəm ‚ant·i·bī′äd·ik]
(microbiology)
An antibiotic that is effective against both gram-negative and gram-positive bacterial species.
References in periodicals archive ?
An increased risk of childhood obesity was observed with greater antibiotic use, particularly for children with 4 or more exposures, when examining all antibiotics or broad-spectrum drugs only.
Once Escalol S UV filter is approved for use in the US by FDA, formulators will have expanded ingredient options to use in their broad-spectrum products, giving consumers added protection from the sun's harmful and skin damaging rays.
Broad-spectrum coverage (label may say "broad spectrum," "protects against UVA/UVB" or "UVA/UVB protection").
Based on the FDA test, the labels of broad-spectrum sunscreens with an SPF of at least 15 can state that, when used properly and with other protective measures, the products can help reduce the risk of skin cancer and the signs of premature aging.
This broad-spectrum fungicide is optimized for use in dry-film applications.
Ceftobiprole (BAL5788), Basilea's lead antibacterial product is the first cephalosporin antibiotic with both anti-MRSA and broad-spectrum activity in late-stage clinical trials.
For suspected ESBLs, the MICs of broad-spectrum cephalosporins were determined by using the agar dilution method.
3,7) Early identification of the disease process, broad-spectrum intravenous antibiotics, aggressive surgical debridement and wound care, and supportive measures such as hyperbaric oxygen are the keys to a successful outcome in CCNF.
For Clavamox, it was this: Your clients trust you and you can trust Clavamox because its broad-spectrum treatment gets results the first time.
Given the likelihood that a woman whose infection has failed to respond to broad-spectrum antibiotics probably has an infected pelvic mass, it makes sense to routinely search for such a mass in nonresponders.
A significant emphasis of the contract solicitation is to aid in the development of broad-spectrum therapies able to demonstrate effectiveness against multiple bioterror pathogens and toxins.